Quris Planning AI-powered Clinical Trial in 2022

Quris Planning AI-powered Clinical Trial in 2022

312471

Quris Planning AI-powered Clinical Trial in 2022

A candidate therapy for fragile X syndrome — developed using Quris’ bio-artificial intelligence clinical prediction platform — will enter clinical trials in 2022, the company announced. Quris is using the power of artificial intelligence (AI)  combined with a “patients-on-a-chip” platform to predict the safety and potential effectiveness of therapeutic candidates before they are used in human trials. “We are at the tipping point of the modernization of drug discovery. I think the Quris platform could be of…

You must be logged in to read/download the full post.